Administrative Core

行政核心

基本信息

  • 批准号:
    10745011
  • 负责人:
  • 金额:
    $ 25.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary The Administrative Core at the Cancer Prevention-Interception against MGUS Progression (CAP-MGUS) Center will provide administrative, scientific, fiscal, and logistic oversight over the whole Center. The Core will also provide clerical support, coordinate interactions between the Bioinformatics Core and Research Projects, and organize regular investigator meetings inside and outside the CAP-MGUS Center. It will bridge the research activities within the CAP-MGUS Center and the NCI CAP-IT program officials to promote collaboration, ensure that the CAP-MGUS Center’s work contributes effectively to issues relevant to the CAP-IT mandates, and maximize dissemination and application of Center discoveries. The Administrative Core has five primary objectives. First, the Core will manage and communicate the research activities within the CAP-MGUS Center. Second, the Administrative Core will promote collaborations on MGUS prevention and interception between the Research Projects and the Bioinformatics Core within the CAP-MGUS Center and collaborations between the Center members and outside investigators. Third, the Administrative Core will organize annual meetings and other network activities. Fourth, the Administrative Core will conduct effective and contextually appropriate outreach. Fifth, the Administrative Core will evaluate existing Research Projects and develop new ones. The CAP-MGUS Center will be one of the few national research consortium centers dedicated to both IgM-MGUS and non-IgM MGUS prevention and interception. The Administrative Core will bring together top experts in MGUS and related cancers and other blood disorders, provide scientific and logistic oversight to Center activities, disseminate scientific knowledge and discoveries, and liaise between Center members and outside stakeholders.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong Li其他文献

A chimeric vacuolar Na+/H+ antiporter gene evolved by DNA family shuf?ing confers increased salt tolerance in yeast
由 DNA 家族改组进化而来的嵌合液泡 Na /H 逆向转运蛋白基因可增强酵母的耐盐性
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yong Li;Hailing Gao;Jiang Wu;Wenzhu Guan
  • 通讯作者:
    Wenzhu Guan

Yong Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong Li', 18)}}的其他基金

Optimizing Syngeneic Mouse Models to Target Mutant p53
优化同基因小鼠模型以靶向突变 p53
  • 批准号:
    10677353
  • 财政年份:
    2023
  • 资助金额:
    $ 25.55万
  • 项目类别:
Cancer Prevention-Interception Against MGUS Progression
癌症预防——阻止 MGUS 进展
  • 批准号:
    10745010
  • 财政年份:
    2023
  • 资助金额:
    $ 25.55万
  • 项目类别:
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI
使用人工智能针对非霍奇金淋巴瘤驱动者进行治疗
  • 批准号:
    10585717
  • 财政年份:
    2022
  • 资助金额:
    $ 25.55万
  • 项目类别:
Dietary Carcinogens for Colorectal Cancer
结直肠癌的膳食致癌物
  • 批准号:
    10160852
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
TP53 Germline Mutations: Beyond LFS
TP53 种系突变:超越 LFS
  • 批准号:
    9912116
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
Dietary Carcinogens for Colorectal Cancer
结直肠癌的膳食致癌物
  • 批准号:
    10401445
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
Modulation of MicroRNAs with Xenobiotics to Target c-Myc
用异生素调节 MicroRNA 以靶向 c-Myc
  • 批准号:
    10018536
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
Dietary Carcinogens for Colorectal Cancer
结直肠癌的膳食致癌物
  • 批准号:
    10040844
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
MYC 作为侵袭性非霍奇金淋巴瘤的生物标志物
  • 批准号:
    10019120
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:
TP53 Germline Mutations: Beyond LFS
TP53 种系突变:超越 LFS
  • 批准号:
    10397062
  • 财政年份:
    2019
  • 资助金额:
    $ 25.55万
  • 项目类别:

相似海外基金

PREDICTING CARIES RISK IN UNDERSERVED CHILDREN, FROM TODDLERS TO THE SCHOOL-AGE YEARS, IN PRIMARY HEALTHCARE SETTINGS
预测初级医疗保健机构中从幼儿到学龄儿童的龋齿风险
  • 批准号:
    10361268
  • 财政年份:
    2021
  • 资助金额:
    $ 25.55万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9751077
  • 财政年份:
    2011
  • 资助金额:
    $ 25.55万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10457019
  • 财政年份:
    2011
  • 资助金额:
    $ 25.55万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    9976990
  • 财政年份:
    2011
  • 资助金额:
    $ 25.55万
  • 项目类别:
Predicting Caries Risk in Underserved Children, from Toddlers to the School-Age Years, in Primary Healthcare Settings
预测初级医疗机构中服务不足的儿童(从幼儿到学龄儿童)的龋齿风险
  • 批准号:
    10213006
  • 财政年份:
    2011
  • 资助金额:
    $ 25.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了